THE WHAT? IM8, the wellness brand co-founded by David Beckham and Prenetics Global, has secured up to US$1 billion in growth financing from venture capital firm General Catalyst to accelerate customer acquisition and expansion.
THE DETAILS The funding will be provided through General Catalyst’s Customer Value Fund, which will finance up to 70% of IM8’s marketing spend in exchange for a capped share of future revenue. Founded in late 2024, IM8 sells science-backed nutritional supplements and is expected to reach an annualised revenue run rate of US$300 million by the end of 2026. Prenetics has also increased its full-year IM8 revenue guidance to US$210 million–US$220 million, marking its second upward revision this year. The company said the financing structure allows it to preserve capital for product innovation, clinical research and strategic growth initiatives.
THE WHY? The financing demonstrates growing investor confidence in the premium wellness sector while highlighting an alternative funding model that enables consumer brands to scale marketing without significant equity dilution or balance sheet pressure.
Source: Bloomberg
